Victory Capital Management
NVS icon

Victory Capital Management’s Novartis NVS Stock Holding History

Victory Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.63M Sell
29,560
-5,872
-17% -$880K ﹤0.01% 1387
2026
Q1 		$5.41M Sell
35,432
-15,600
-31% -$2.39M ﹤0.01% 1293
2025
Q4 		$7.04M Sell
51,032
-24,432
-32% -$3.2M ﹤0.01% 1175
2025
Q3 		$9.68M Sell
75,464
-2,640
-3% -$322K 0.01% 1118
2025
Q2 		$9.45M Sell
78,104
-44,926
-37% -$5.06M 0.01% 1133
2025
Q1 		$13.7M Buy
123,030
+26,789
+28% +$2.85M 0.01% 939
2024
Q4 		$9.37M Buy
+96,241
New +$10.3M 0.01% 1103
2024
Q1 		– Sell
-6,260
Closed -$632K – 2548
2023
Q4 		$632K Sell
6,260
-15,130
-71% -$1.46M ﹤0.01% 1928
2023
Q3 		$2.18M Hold
21,390
– – ﹤0.01% 1362
2023
Q2 		$2.16M Sell
21,390
-1,883
-8% -$188K ﹤0.01% 1366
2023
Q1 		$2.14M Buy
+23,273
New +$2.03M ﹤0.01% 1383
2019
Q4 		– Sell
-14,607
Closed -$1.27M – 3047
2019
Q3 		$1.27M Buy
+14,607
New +$1.31M ﹤0.01% 1640
2018
Q3 		– Sell
-84,291
Closed -$5.71M – 1855
2018
Q2 		$5.71M Sell
84,291
-11,003
-12% -$759K 0.01% 825
2018
Q1 		$6.9M Buy
+95,294
New +$7.25M 0.02% 793

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Victory Capital Management's NVS Position: Q2 2026 in Review

Victory Capital Management reduced its Novartis (NVS) stake by 17% in Q2 2026, selling an estimated $880K and leaving 29,560 shares worth $4.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

Victory Capital Management first reported a position in NVS in Q1 2018 and has held it in 14 quarters since. The position peaked at $13.7M in Q1 2025. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Victory Capital Management held 29,560 shares of Novartis worth $4.63M as of Q2 2026.
  • Victory Capital Management sold 5,872 Novartis shares in Q2 2026, an estimated $880K.
  • Novartis made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1387 holding.
  • Victory Capital Management first reported a position in Novartis in Q1 2018 and has held it in 14 quarters since.
  • Victory Capital Management's Novartis position peaked at $13.7M in Q1 2025.
  • 1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.